ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,591Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1383

$1.25M Total Retail Price of All Prescriptions

Rank: 32 out of 1383

794 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 794 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 794 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 21,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 984 894 1 3
SIMVASTATIN 971 853 2 2
OMEPRAZOLE 842 701 3 5
LEVOTHYROXINE SODIUM 705 642 4 4
HYDROCODONE-ACETAMINOPHEN 658 469 S3 5 1
ATORVASTATIN CALCIUM 607 540 6 18
WARFARIN SODIUM 511 383 7 13
FUROSEMIDE 461 421 8 7
AMLODIPINE BESYLATE 389 329 9 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 384 299 10 27
MIRTAZAPINE 356 322 11 51
CARVEDILOL 347 298 12 24
DILTIAZEM 24HR CD 316 284 13 95
METOPROLOL SUCCINATE 310 295 14 29
SERTRALINE HCL 308 256 15 21
METOPROLOL TARTRATE 299 268 16 9
LOVASTATIN 285 270 17 22
POTASSIUM CHLORIDE 284 239 18 12
METFORMIN HCL 277 196 19 8
TRAZODONE HCL 277 218 19 36
FENOFIBRATE 275 228 21 65
ALENDRONATE SODIUM 274 259 22 37
GABAPENTIN 265 219 23 11
DIVALPROEX SODIUM 259 233 24 78
MELOXICAM 253 232 25 20
NAMENDA 238 220 26 49
CITALOPRAM HBR 237 219 27 15
DONEPEZIL HCL 233 227 28 35
ATENOLOL 228 222 29 16
ZOLPIDEM TARTRATE 226 177 30 17
PANTOPRAZOLE SODIUM 226 211 30 32
NIFEDIPINE ER 223 205 32 126
METFORMIN HCL ER 213 198 33 47
LOSARTAN POTASSIUM 210 203 34 23
ALLOPURINOL 203 190 35 33
TERAZOSIN HCL 199 185 36 111
FLUTICASONE PROPIONATE 185 141 37 39
SPIRIVA 179 154 38 45
TRAMADOL HCL 178 146 39 25
OXYBUTYNIN CHLORIDE ER 176 175 40 173
DIGOXIN 162 151 41 59
GLYBURIDE-METFORMIN HCL 162 152 R 41 172
TAMSULOSIN HCL 156 136 43 30
CLONIDINE HCL 154 142 44 44
LANTUS 153 135 45 50
CYMBALTA 149 114 46 53
LOSARTAN-HYDROCHLOROTHIAZIDE 148 123 47 60
TRIAMTERENE-HCTZ 143 126 48 48
GLIPIZIDE ER 141 117 49 157
DOXAZOSIN MESYLATE 136 131 50 120
HYDROCHLOROTHIAZIDE 136 131 50 10
CRESTOR 135 119 52 34
AZITHROMYCIN 133 121 53 41
RANITIDINE HCL 128 101 54 19
EXELON 123 110 55 117
PROAIR HFA 122 87 56 42
EVISTA 121 121 57 152
CLOPIDOGREL 114 108 58 28
FLUOXETINE HCL 108 87 59 52
LEVEMIR 107 99 60 145
PRAVASTATIN SODIUM 100 94 61 14
CYCLOBENZAPRINE HCL 97 41 R 62 69
KLOR-CON M20 95 76 63 100
ATENOLOL-CHLORTHALIDONE 95 95 63 149
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 74 65 89
PREDNISONE 92 85 66 40
ROPINIROLE HCL 90 77 67 79
NOVOLOG 89 79 68 139
SPIRONOLACTONE 89 69 68 67
QUETIAPINE FUMARATE 88 88 70 70
LEVOFLOXACIN 87 73 71 88
FENTANYL 82 71 S2 72 92
CALCITONIN-SALMON 79 77 73 346
PLAVIX 78 70 74 43
PROMETHAZINE HCL 77 45 R 75 56
DILTIAZEM 24HR ER 74 65 76 161
ADVAIR DISKUS 74 70 76 63
IPRATROPIUM-ALBUTEROL 74 74 76 138
CIPROFLOXACIN HCL 74 61 76 54
BENAZEPRIL HCL 73 69 80 38
GLYBURIDE 73 52 R 80 46
BACLOFEN 70 45 82 118
PEN NEEDLE 63 54 83 147
LEVETIRACETAM 63 56 83 134
LIPITOR 62 47 85 158
KLOR-CON M10 62 60 85 179
OXYCODONE HCL-ACETAMINOPHEN 62 43 S2 85 81
NOVOLIN R 62 59 85 167
ALBUTEROL SULFATE 61 55 89 124
CARBIDOPA-LEVODOPA 61 53 89 108
OXYCODONE-ACETAMINOPHEN 61 29 S2 89 107
NYSTATIN 60 51 92 132
GLIPIZIDE 60 44 92 98
RISPERIDONE 58 58 94 71
FINASTERIDE 58 58 94 121
OXYCODONE HCL 57 31 S2 96 62
NYSTATIN-TRIAMCINOLONE 57 57 96 275
NYSTOP 56 52 98 294
HUMALOG 56 54 98 176
ZETIA 56 55 98 101
BYSTOLIC 56 44 98 181
KLOR-CON 10 55 55 102 74
SEROQUEL 55 54 102 130
JANUVIA 55 48 102 85
AMANTADINE 54 50 105 430
AMITRIPTYLINE HCL 53 28 R 106 57
MUPIROCIN 52 43 107 189
ISOSORBIDE MONONITRATE ER 51 40 108 66
SINGULAIR 50 42 109 82
NABUMETONE 50 44 109 156
HUMULIN R 50 35 109 215
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.